Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib (ELIOS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03239340
Recruitment Status : Active, not recruiting
First Posted : August 4, 2017
Last Update Posted : October 20, 2021
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 14, 2022
Estimated Study Completion Date : October 16, 2022